ELTX Covered Call Strategy
ELTX (Elicio Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
ELTX (Elicio Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $76.3M, a beta of 1.44 versus the broader market, a 52-week range of 2.66-16, average daily share volume of 1.4M, a public-listing history dating back to 2021, approximately 32 full-time employees. These structural characteristics shape how ELTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.44 indicates ELTX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on ELTX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current ELTX snapshot
As of June 29, 2026, spot at $4.07, ATM IV 21.00%, IV rank 0.02%, expected move 6.02%. The covered call on ELTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this covered call structure on ELTX specifically: ELTX IV at 21.00% is on the cheap side of its 1-year range, which means a premium-selling ELTX covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 6.02% (roughly $0.25 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ELTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on ELTX should anchor to the underlying notional of $4.07 per share and to the trader's directional view on ELTX stock.
ELTX covered call setup
The ELTX covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ELTX near $4.07, the first option leg uses a $4.27 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ELTX chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ELTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $4.07 | long |
| Sell 1 | Call | $4.27 | N/A |
ELTX covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ELTX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ELTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on ELTX
Covered calls on ELTX are an income strategy run on existing ELTX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ELTX thesis for this covered call
The market-implied 1-standard-deviation range for ELTX extends from approximately $3.82 on the downside to $4.32 on the upside. A ELTX covered call collects premium on an existing long ELTX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ELTX will breach that level within the expiration window. Current ELTX IV rank near 0.02% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ELTX at 21.00%. As a Healthcare name, ELTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ELTX-specific events.
ELTX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ELTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ELTX alongside the broader basket even when ELTX-specific fundamentals are unchanged. Short-premium structures like a covered call on ELTX carry tail risk when realized volatility exceeds the implied move; review historical ELTX earnings reactions and macro stress periods before sizing. Always rebuild the position from current ELTX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ELTX?
- A covered call on ELTX is the covered call strategy applied to ELTX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ELTX stock trading near $4.07, the strikes shown on this page are snapped to the nearest listed ELTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ELTX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ELTX covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 21.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ELTX covered call?
- The breakeven for the ELTX covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ELTX market-implied 1-standard-deviation expected move is approximately 6.02%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ELTX?
- Covered calls on ELTX are an income strategy run on existing ELTX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ELTX implied volatility affect this covered call?
- ELTX ATM IV is at 21.00% with IV rank near 0.02%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.